Position in FATE
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$27,264
+$15,147 QoQ
Shares Held
10,098
0.0% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#113
of 155 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Westmount Partners, LLC holds $2,556,295 across 6 Biotechnology names. FATE ranks #6 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
12,961 | $1,027,677 | |
| 2 | NTHI |
Neonc Technologies Holdings, Inc.
|
197,178 | $893,216 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,000 | $301,030 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,118 | $232,228 | |
| 5 | ALLO |
Allogene Therapeutics, Inc.
|
36,000 | $74,880 | |
| 6 | FATE |
Fate Therapeutics Inc
This page
|
10,098 | $27,264 |
All Filings in FATE
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,264 | 10,098 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $12,117 | 10,098 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $9,896 | 10,098 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $12,723 | 10,098 | Shares | Sole | 2025-10-14 | |
| No filing history on record for this holder in this stock. | ||||||